Skip to main content
Erschienen in: Digestive Diseases and Sciences 5/2011

01.05.2011 | Original Article

Inflammatory Bowel Disease Characteristics and Treatment in Hispanics and Caucasians

verfasst von: Jason Hou, Hashem El-Serag, Joseph Sellin, Selvi Thirumurthi

Erschienen in: Digestive Diseases and Sciences | Ausgabe 5/2011

Einloggen, um Zugang zu erhalten

Abstract

Background

Many inflammatory bowel disease (IBD) studies have focused on Caucasian patients and little data exist on IBD in Hispanics living in the United States.

Aim

The aim of our study was to compare IBD characteristics between Hispanic and Caucasian patients in the Harris County Hospital District (HCHD).

Methods

We identified patients within the HCHD with a diagnosis of Crohn’s disease (CD) or ulcerative colitis (UC) recorded during 2000–2006. Primary medical record review was performed to confirm the diagnosis and to abstract data on patient demographics, disease characteristics and treatment.

Results

A total of 69 Hispanic and 83 Caucasian patients with confirmed IBD were analyzed. Hispanics were diagnosed with IBD at an older age than Caucasians (mean age 37.8 SD 16 vs. mean age 29.0 SD 14, P < 0.01). In Hispanics with IBD, there was a lower proportion of patients with CD compared to Caucasians with IBD (36% vs. 65%, P < 0.01). Although there were no significant differences in diagnostic examinations or medication prescription between the two groups, there was a higher number of bowel resections per patient in Caucasians compared with Hispanics (0.5 vs. 0.22, P = 0.01).

Conclusions

Hispanics with IBD were diagnosed at a significantly older age than Caucasians and had a lower number of bowel resections per patient. In Hispanics with IBD, UC was more common than CD while CD was more common than UC among Caucasians with IBD. Further research is required to confirm these observations and determine if these findings reflect genetic or environmental differences.
Literatur
1.
Zurück zum Zitat Loftus EV Jr. Clinical epidemiology of inflammatory bowel disease: incidence, prevalence, and environmental influences. Gastroenterology. 2004;126:1504–1517.PubMedCrossRef Loftus EV Jr. Clinical epidemiology of inflammatory bowel disease: incidence, prevalence, and environmental influences. Gastroenterology. 2004;126:1504–1517.PubMedCrossRef
2.
Zurück zum Zitat Hanauer SB, Feagan BG, Lichtenstein GR, et al. ACCENT I study group. Maintenance infliximab for Crohn’s disease: the ACCENT I randomized trial. Lancet. 2002;359:1541–1549.PubMedCrossRef Hanauer SB, Feagan BG, Lichtenstein GR, et al. ACCENT I study group. Maintenance infliximab for Crohn’s disease: the ACCENT I randomized trial. Lancet. 2002;359:1541–1549.PubMedCrossRef
3.
Zurück zum Zitat Sands BE, Anderson FH, Bernstein CN, et al. Infliximab maintenance therapy for fistulizing Crohn’s disease. N Engl J Med. 2004;350:876–885.PubMedCrossRef Sands BE, Anderson FH, Bernstein CN, et al. Infliximab maintenance therapy for fistulizing Crohn’s disease. N Engl J Med. 2004;350:876–885.PubMedCrossRef
4.
Zurück zum Zitat Vind I, Riis L, Jess T, et al. Increasing incidences of inflammatory bowel disease and decreasing surgery rates in Copenhagen city and county, 2003–2005: a population-based study from the Danish crohn colitis database. Am J Gastroenterol. 2006;101:1274–1282.PubMedCrossRef Vind I, Riis L, Jess T, et al. Increasing incidences of inflammatory bowel disease and decreasing surgery rates in Copenhagen city and county, 2003–2005: a population-based study from the Danish crohn colitis database. Am J Gastroenterol. 2006;101:1274–1282.PubMedCrossRef
6.
Zurück zum Zitat Kurata JH, Kantor-Fish S, Frankl H, et al. Crohn’s disease among ethnic groups in a large health maintenance organization. Gastroenterology. 1992;102:1940–1948.PubMed Kurata JH, Kantor-Fish S, Frankl H, et al. Crohn’s disease among ethnic groups in a large health maintenance organization. Gastroenterology. 1992;102:1940–1948.PubMed
7.
Zurück zum Zitat Appleyard CB, Hernández G, Rios-Bedoya CF. Basic epidemiology of inflammatory bowel disease in Puerto Rico. Inflamm Bowel Dis. 2004;10:106–111.PubMedCrossRef Appleyard CB, Hernández G, Rios-Bedoya CF. Basic epidemiology of inflammatory bowel disease in Puerto Rico. Inflamm Bowel Dis. 2004;10:106–111.PubMedCrossRef
8.
Zurück zum Zitat Hou JK, El-Serag H, Thirumurthi S. Distribution and manifestations of inflammatory bowel disease in Asians, Hispanics, and African Americans: a systematic review. Am J Gastroenterol. 2009;104:2100–2109.PubMedCrossRef Hou JK, El-Serag H, Thirumurthi S. Distribution and manifestations of inflammatory bowel disease in Asians, Hispanics, and African Americans: a systematic review. Am J Gastroenterol. 2009;104:2100–2109.PubMedCrossRef
9.
Zurück zum Zitat Nguyen GC, Torres EA, Regueiro M, et al. Inflammatory bowel disease characteristics among African Americans, Hispanics, and non-Hispanic whites: characterization of a large north American cohort. Am J Gastroenterol. 2006;101:1012–1023.PubMedCrossRef Nguyen GC, Torres EA, Regueiro M, et al. Inflammatory bowel disease characteristics among African Americans, Hispanics, and non-Hispanic whites: characterization of a large north American cohort. Am J Gastroenterol. 2006;101:1012–1023.PubMedCrossRef
10.
Zurück zum Zitat Moreno JM, Rubio CE, Torres EA. Inflammatory disease of the gastrointestinal tract at the University Hospital, Medical Center, Puerto Rico. 1980–87. Bol Asoc Med P R. 1989;81:214–218.PubMed Moreno JM, Rubio CE, Torres EA. Inflammatory disease of the gastrointestinal tract at the University Hospital, Medical Center, Puerto Rico. 1980–87. Bol Asoc Med P R. 1989;81:214–218.PubMed
11.
Zurück zum Zitat Finlay DG, Basu D, Sellin JH. Effect of race and ethnicity on perceptions of inflammatory bowel disease. Inflamm Bowel Dis. 2006;12:503–507.PubMedCrossRef Finlay DG, Basu D, Sellin JH. Effect of race and ethnicity on perceptions of inflammatory bowel disease. Inflamm Bowel Dis. 2006;12:503–507.PubMedCrossRef
12.
Zurück zum Zitat Torres EA, De Jesús R, Pérez CM, et al. Prevalence of inflammatory bowel disease in an insured population in Puerto Rico during 1996. P R Health Sci J. 2003;22:253–258.PubMed Torres EA, De Jesús R, Pérez CM, et al. Prevalence of inflammatory bowel disease in an insured population in Puerto Rico during 1996. P R Health Sci J. 2003;22:253–258.PubMed
14.
Zurück zum Zitat Satsangi J, Silverberg MS, Vermeire S, Colombel JF. The montreal classification of inflammatory bowel disease: controversies, consensus, and implications. Gut. 2006;55:749–753.PubMedCrossRef Satsangi J, Silverberg MS, Vermeire S, Colombel JF. The montreal classification of inflammatory bowel disease: controversies, consensus, and implications. Gut. 2006;55:749–753.PubMedCrossRef
15.
Zurück zum Zitat Basu D, Lopez I, Kulkarni A, et al. Impact of race and ethnicity on inflammatory bowel disease. Am J Gastroenterol. 2005;100:2254–2261.PubMedCrossRef Basu D, Lopez I, Kulkarni A, et al. Impact of race and ethnicity on inflammatory bowel disease. Am J Gastroenterol. 2005;100:2254–2261.PubMedCrossRef
Metadaten
Titel
Inflammatory Bowel Disease Characteristics and Treatment in Hispanics and Caucasians
verfasst von
Jason Hou
Hashem El-Serag
Joseph Sellin
Selvi Thirumurthi
Publikationsdatum
01.05.2011
Verlag
Springer US
Erschienen in
Digestive Diseases and Sciences / Ausgabe 5/2011
Print ISSN: 0163-2116
Elektronische ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-011-1629-7

Weitere Artikel der Ausgabe 5/2011

Digestive Diseases and Sciences 5/2011 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Echinokokkose medikamentös behandeln oder operieren?

06.05.2024 DCK 2024 Kongressbericht

Die Therapie von Echinokokkosen sollte immer in spezialisierten Zentren erfolgen. Eine symptomlose Echinokokkose kann – egal ob von Hunde- oder Fuchsbandwurm ausgelöst – konservativ erfolgen. Wenn eine Op. nötig ist, kann es sinnvoll sein, vorher Zysten zu leeren und zu desinfizieren. 

Umsetzung der POMGAT-Leitlinie läuft

03.05.2024 DCK 2024 Kongressbericht

Seit November 2023 gibt es evidenzbasierte Empfehlungen zum perioperativen Management bei gastrointestinalen Tumoren (POMGAT) auf S3-Niveau. Vieles wird schon entsprechend der Empfehlungen durchgeführt. Wo es im Alltag noch hapert, zeigt eine Umfrage in einem Klinikverbund.

Proximale Humerusfraktur: Auch 100-Jährige operieren?

01.05.2024 DCK 2024 Kongressbericht

Mit dem demographischen Wandel versorgt auch die Chirurgie immer mehr betagte Menschen. Von Entwicklungen wie Fast-Track können auch ältere Menschen profitieren und bei proximaler Humerusfraktur können selbst manche 100-Jährige noch sicher operiert werden.

Die „Zehn Gebote“ des Endokarditis-Managements

30.04.2024 Endokarditis Leitlinie kompakt

Worauf kommt es beim Management von Personen mit infektiöser Endokarditis an? Eine Kardiologin und ein Kardiologe fassen die zehn wichtigsten Punkte der neuen ESC-Leitlinie zusammen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.